What is MRK's current stock price?

MRK is currently trading at $120.28 with a daily change of +0.38%. Visit StocksRunner for live updates.

What are MRK stock's key strengths?

MRK current strengths include: Investors confidence is positive, Outperform the market, Earnings are forecast to grow, Trading below its fair value, Upgraded on attractively valued. These are updated in real time by the StocksRunner IQ algorithm.

What are the risks associated with MRK stock?

Current risk factors for MRK include: Low. Risk levels are assessed by StocksRunner based on volatility, sector strength, volume, and investor confidence.

What is MRK's current StocksRunner IQ Score?

MRK current StocksRunner IQ Score is: Strong Buy. This score reflects aggregated earnings data, news sentiment, analyst ratings, and market momentum as of the latest update.

What factors influence MRK's StocksRunner IQ Score?

MRK StocksRunner IQ Score is a composite Credibility Score that weighs: quarterly earnings results vs. analyst expectations, breaking news sentiment and headline credibility, Wall Street analyst price target consensus, trading volume and price momentum, and sector-level risk indicators. All factors are aggregated in real time.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

MRK Stock Analysis & IQ Rating | Merck Company

Q: Should I buy MRK stock right now?

StocksRunner does not provide personalized investment advice. Our IQ Credibility Score for MRK aggregates analyst sentiment, earnings performance, and news momentum to help you make an informed decision. The current IQ signal is: Strong Buy. Always consider your own risk tolerance and consult a financial advisor before investing.

Q: What does a Strong Buy rating mean for MRK?

A Strong Buy rating on StocksRunner indicates that the aggregated IQ score — drawing from earnings beats, analyst upgrades, and positive news sentiment — reflects high confidence in MRK near-term growth potential. It is the strongest signal in the StocksRunner IQ rating scale.

MRK MRK Badge

Merck Company

$120.28

+$0.46 | +0.38%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$125.14

MKT CAP

$297.38B

52W Low

$73.31

VOL

$6.32M

P/E Ratio

N/A

AVG VOL

$12.84M

RSI

55.49

TREND

Uptrend

MRK Stock IQ

Login to see Merck Company (MRK) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

MRK Target Price

Login to display

Strengths

MRK Rewards

Earnings are forecast to grow

MRK Rewards

Upgraded on attractively valued

MRK Rewards

Outperform the market

MRK Rewards

Trading below its fair value

MRK Price Performance

$121.93 (-1.35%)

$98.93 (+21.58%)

$87.5 (+37.46%)

$93.11 (+29.18%)

1year

6month

3month

1month

MRK Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

MRK Analysts opinion is positive and also has improved from the past 3 months

MRK Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

76%

Consensus Rating

100%

Buy
Opinion

67%

Trend
Score

83%

Potential
Score

MRK Street Sentiment is extremely bullish and have positive views on the near-term outlook

MRK Risk Level

MRK has Low risk level

Low

LOW

HIGH

MRK Performance Sentiment

Sentiments overview associated with events and the stock performance

76%

Positive

62 out of 82
events present

23%

Negative

19 out of 82
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price

$111.01

Resistance Price

$121.93

Current Price Range

$120.34

$111.01

$121.93

Show methods +

Analyst Consensus

Recent Upgrades and Downgrades

78%

Consensus Rating

BUY

7

Buy

2

Hold

0

Sell

Date

Action

Rating

Firm

Jan 20, 2026

Upgrade

Buy

BMO Capital

Jan 09, 2026

Upgrade

Outperform

Wolfe Research

Jan 08, 2026

Upgrade

Outperform

Wolfe Research

Dec 19, 2025

Upgrade

Outperform

BMO Capital

Dec 18, 2025

Price Target Raised

Outperform

BMO Capital

Runners Also Watch

Close Price

Change

SNY

Sanofi

46.22

-0.54%

AZN

Astrazeneca

201.53

-0.11%

PFE

Pfizer

26.62

+0.08%

MLTX

MoonLake Immunotherapeuti

18.14

+2.54%

ABBV

AbbVie

236.19

+1.03%

MRK Latest Analysis +

AI-Powered Tempus Inks New Multi-Year Merck Deal. Tempus AI Inc. (NASDAQ:TEM) on Tuesday inked a strategic collaboration agreement with Merck &. Co. Inc. (NYSE:MRK) aimed at accelerating AI-driven precision medicine.The stock’.s decline comes as broader markets experienced significant sell-offs with major indices like the S&.P 500 and Nasdaq both trading lower today.Tempus announced an expanded multi-year collaboration with Merck to enhance the discovery and development of precision m

Tue Mar 3, 2026

$119.83 | -1.25%

Activity

Merck to collaborate with Tempus AI on precision oncology.

Tue Mar 3, 2026

$119.83 | -1.25%

Activity

Is It Worth Investing in Merck (MRK) Based on Wall Streets ish Views?. The average brokerage recommendation (ABR) for Merck (MRK) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So is it worth buying the stock?

Mon Mar 2, 2026

$121.41 | -1.95%

Potential

LGND: 2025 Results & Focus on Qtorin. By John Vandermosten CFANASDAQ:LGNDREAD THE FULL LGND RESEARCH REPORTLigand Pharmaceuticals Inc. (NASDAQ:LGND) reported 2025 results with revenues of $268 million and adjusted core earnings per share (EPS) of $8.13. Both numbers were substantially better than initial and revised 2025 guidance. Isolating the fourth quarter results revenues from royalties were markedly better than our estimates while Captisol revenue was slightly below and the highly volatile

Mon Mar 2, 2026

$121.41 | -1.95%

Potential

Merck Stock Up 18% In 2026 Ticks Another Box. Is It Now A Buy?.

Merck stock ticked another box Friday after the firm said its Keytruda-containing regimen improved outcomes for ovarian cancer patients.

The post Merck Stock Up 18% In 2026 Ticks Another Box. Is It Now A Buy? appeared first on Investor'.s Business Daily.

Fri Feb 27, 2026

$123.82 | +3.79%

Momentum

Merck Cuts Staff at Gardasil Plant Amid Slump in Global Demand. Merck &. Co. is cutting staff at a US plant that makes its HPV vaccine Gardasil amid a decrease in global demand for the cancer-preventing shot.

Fri Feb 27, 2026

$123.82 | +3.79%

Activity

Momentum

Merck Stock Up 13% In 2026 Ticks Another Box. Is It Now A Buy?. Merck stock ticked another box Friday after the firm said its Keytruda-containing regimen improved outcomes for ovarian cancer patients.The post Merck Stock Up 13% In 2026 Ticks Another Box. Is It Now A Buy? appeared first on Investor'.s Business Daily.

Fri Feb 27, 2026

$123.82 | +3.79%

Momentum

Merck wins FDA approval of Numelvi for itching in dogs.

Thu Feb 26, 2026

$119.30 | -2.58%

Activity

RBC Capital Sees Merck (MRK) Returning to Growth Sooner Than Market Expects. Merck &. Co. Inc. (NYSE:MRK) is included among the 14 Best Affordable Dividend Stocks to Buy According to Analysts. On February 25 RBC Capital initiated coverage of Merck &. Co. Inc. (NYSE:MRK) with an Outperform rating and a $142 price target. The firm believes investor interest in the stock could continue supported by upcoming product [….]

Thu Feb 26, 2026

$119.30 | -2.58%

Potential

How Is The Market Feeling About Merck & Co Inc?. Merck &. Co Inc'.s (NYSE:MRK) short interest as a percent of float has fallen 14.57% since its last report. According to exchange reported data there are now 28.73 million shares sold short which is 1.29% of all regular shares that are available for trading. Based on its trading volume it would take traders 2.38 days to cover their short positions on average.Why Short Interest MattersShort interest is the number of shares that have been sol

Wed Feb 25, 2026

$122.46 | -1.19%

Activity

FAQ About MRK Stock Insights

What is MRK current stock price?

What are MRK stock strengths?

What is MRK Risk Level?

What is MRK market cap and volume?

What is MRK current Stock IQ?

Should I buy MRK stock right now?

Is MRK a Strong Buy right now?

What does a 'Strong Buy' rating mean for MRK?

What does a 'Strong Sell' rating mean for MRK?

What factors influence MRK's Stock IQ?

Explore our MRK Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored MRK Stock Strategies
Effective Risk Management

FIND US ON

Receive our MRK Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

MRK MRK Badge

Merck Company

Set Alerts

Current Price

$120.28

+$0.46 | +0.38%

52W High

$125.14

MKT CAP

$297.38B

52W Low

$73.31

VOL

$6.32M

P/E Ratio

N/A

AVG VOL

$12.84M

RSI

55.49

TREND

Uptrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Runners Also Watch

Symbol

Close

Change

SNY

Sanofi

46.22

-0.54%

AZN

Astrazeneca

201.53

-0.11%

PFE

Pfizer

26.62

+0.08%

MLTX

MoonLake Immunotherapeuti

18.14

+2.54%

ABBV

AbbVie

236.19

+1.03%

MRK Price Performance

$121.93 (-1.35%)

$98.93 (+21.58%)

$87.5 (+37.46%)

$93.11 (+29.18%)

1year

6month

3month

1month

MRK Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

MRK Analysts opinion is positive and also has improved from the past 3 months

MRK Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

76%

Consensus Rating

100%

Buy
Opinion

67%

Trend
Score

83%

Potential
Score

MRK Street Sentiment is extremely bullish and have positive views on the near-term outlook

MRK Risk Level

MRK has Low risk level

Low

LOW

HIGH

MRK Performance Sentiment

Sentiments overview associated with events and the stock performance.

76%

Positive

62 out of 82
events present

23%

Negative

19 out of 82
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price

$111.01

Resistance Price

$121.93

Current Price Range

$120.34

$111.01

$121.93

Show methods +

Latest Analyst Actions

Overall Wall Street Rating

78%

Consensus Rating

BUY

7

Buy

2

Hold

0

Sell

Date

Action

Rating

Firm

Jan 20, 2026

Upgrade

Buy

BMO Capital

Jan 09, 2026

Upgrade

Outperform

Wolfe Research

Jan 08, 2026

Upgrade

Outperform

Wolfe Research

Dec 19, 2025

Upgrade

Outperform

BMO Capital

Dec 18, 2025

Price Target Raised

Outperform

BMO Capital

MRK Stock IQ

Login to unlock Merck Company (MRK) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

MRK Rewards

Earnings are forecast to grow

MRK Rewards

Upgraded on attractively valued

MRK Rewards

Outperform the market

MRK Rewards

Trading below its fair value

MRK Latest Analysis

AI-Powered Tempus Inks New Multi-Year Merck Deal. Tempus AI Inc. (NASDAQ:TEM) on Tuesday inked a strategic collaboration agreement with Merck &. Co. Inc. (NYSE:MRK) aimed at accelerating AI-driven precision medicine.The stock’.s decline comes as broader markets experienced significant sell-offs with major indices like the S&.P 500 and Nasdaq both trading lower today.Tempus announced an expanded multi-year collaboration with Merck to enhance the discovery and development of precision m

Tue Mar 3, 2026

$119.83 | -1.25%

Activity

Merck to collaborate with Tempus AI on precision oncology.

Tue Mar 3, 2026

$119.83 | -1.25%

Activity

Is It Worth Investing in Merck (MRK) Based on Wall Streets ish Views?. The average brokerage recommendation (ABR) for Merck (MRK) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So is it worth buying the stock?

Mon Mar 2, 2026

$121.41 | -1.95%

Potential

LGND: 2025 Results & Focus on Qtorin. By John Vandermosten CFANASDAQ:LGNDREAD THE FULL LGND RESEARCH REPORTLigand Pharmaceuticals Inc. (NASDAQ:LGND) reported 2025 results with revenues of $268 million and adjusted core earnings per share (EPS) of $8.13. Both numbers were substantially better than initial and revised 2025 guidance. Isolating the fourth quarter results revenues from royalties were markedly better than our estimates while Captisol revenue was slightly below and the highly volatile

Mon Mar 2, 2026

$121.41 | -1.95%

Potential

Merck Stock Up 18% In 2026 Ticks Another Box. Is It Now A Buy?.

Merck stock ticked another box Friday after the firm said its Keytruda-containing regimen improved outcomes for ovarian cancer patients.

The post Merck Stock Up 18% In 2026 Ticks Another Box. Is It Now A Buy? appeared first on Investor'.s Business Daily.

Fri Feb 27, 2026

$123.82 | +3.79%

Momentum

Merck Cuts Staff at Gardasil Plant Amid Slump in Global Demand. Merck &. Co. is cutting staff at a US plant that makes its HPV vaccine Gardasil amid a decrease in global demand for the cancer-preventing shot.

Fri Feb 27, 2026

$123.82 | +3.79%

Activity

Momentum

Merck Stock Up 13% In 2026 Ticks Another Box. Is It Now A Buy?. Merck stock ticked another box Friday after the firm said its Keytruda-containing regimen improved outcomes for ovarian cancer patients.The post Merck Stock Up 13% In 2026 Ticks Another Box. Is It Now A Buy? appeared first on Investor'.s Business Daily.

Fri Feb 27, 2026

$123.82 | +3.79%

Momentum

Discover MRK Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of MRK. We're here to help you make informed investment decisions today.

FIND US ON

Receive our MRK Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

MRK Stock trends

MRK Stock performance

MRK Stock analysis

MRK investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing MRK

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing MRK

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

MRK Stock Analysis & IQ Rating | Merck Company

MRK Stock IQ

MRK Target Price

MRK Analysts Opinion

MRK Street Sentiment

MRK Risk Level

MRK Performance Sentiment

Key Price Levels

Analyst Consensus

Explore our MRK Stock insights

Receive our MRK Daily Alerts

MRK Street Sentiment

MRK Risk Level

Key Price Levels

Latest Analyst Actions

Discover MRK Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of MRK. We're here to help you make informed investment decisions today.

Receive our MRK Daily Alerts

MRK Alerts